Skip to main content

Table 1 Classification of xenograft tumors based on TNBC subtypes

From: Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition

Xenograft ID TNBC subtype
SUTI097 immunomodulatory (IM)
SUTI103 basal-like 1 (BL1)
SUTI110 basal-like 1 (BL1)
SUTI151 basal-like 2 (BL2)
SUTI151M mesenchymal (M)
SUTI319 unstable (UNS)
SUTI368 unstable (UNS)
  1. TNBC, Triple-negative breast cancer.